Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liraglutide Use in Prader-Willi Syndrome

NCT01542242 is registered in ClinicalTrials.gov with Vancouver General Hospital as lead sponsor.

NCT NCT01542242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01542242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liraglutide Use in Prader-Willi Syndrome
Lead sponsor
Vancouver General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
February 29, 2012
Completion date
March 31, 2013
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2, prader willi syndrome